Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study
Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study. // Journal of Clinical and Experimental Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0973688326001490?dgcid=rss_sd_all
Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study. Journal of Clinical and Experimental Hepatology. https://www.sciencedirect.com/science/article/pii/S0973688326001490?dgcid=rss_sd_all
“Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study.” Journal of Clinical and Experimental Hepatology.
@article{article52625,
title = {Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study},
journal = {Journal of Clinical and Experimental Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0973688326001490?dgcid=rss_sd_all}
}